Analytik Jena has acquired all of the assets of the insolvent company SIRS-Lab GmbH as part of an asset deal. SIRS-Lab, a company that develops molecular diagnostics methods and testing systems for life-threatening infections like sepsis, had filed for insolvency in December 2012. Analytik ... more
Analytik Jena AG Announces Group Figures for Financial Year 2010/2011
Growth expected for financial year 2011/2012 with a quieter first quarter
19-12-2011: In the past financial year 2010/2011, the Analytik Jena AG was again able to increase its revenue significantly. Overall, the Group generated sales of EUR 86.3 m (previous year: EUR 80.2 m), a 7.6 % increase on the previous year. In the process, Analytik Jena again surpassed the record achieved in the previous year. Operating profit (EBIT) amounted to EUR 5.0 m (previous year: EUR 3.1 m), up 59.3 % year-on-year.
"After the previous financial year was basically characterized by one-time effects, we succeeded in growing our operating result again." commented Klaus Berka, CEO of Analytik Jena AG. "We could again increase in sales and exceed the record level of sales we set last year. We achieved this due to the outstanding development in our largest business area, Analytical Instrumentation that managed to grow its revenue by 11.3 % last year based on its traditionally strong export operations."
Revenue Development and Segments
From a strong competitive position in the optical spectroscopy sector, the Analytical Instrumentation business unit was again able to win market share in the reporting period and increase its revenue. Analytik Jena closed the financial year in this segment with revenue of EUR 53.2 m (previous year: EUR 47.8 m), representing a gain of 11.3 %. Life Science business unit recorded sales of EUR 28.3 m (previous year: EUR 27.5 m), 2.7 % higher than in the previous year. The Optics segment was able to halt a three-year downward slide caused by economic conditions, nearly matching the previous year's level. Revenue in financial year 2010/2011 totaled EUR 4.8 m (previous year: EUR 4.9 m). That equates to a slight decrease of 1.1 %.
Financial Position and Results of Operations
The Group ended the full financial year of 2010/2011 with earnings before interest, taxes, depreciation, and amortization (EBITDA) of EUR 8.8 m (previous year: EUR 6.7 m) and operating profit of EUR 5.0 m (previous year: EUR 3.1 m). In the process, Analytik Jena recorded increases in EBITDA of 31.0 % and EBIT of 59.3 %. Once again, the Company achieved a double-digit EBITDA margin of 10.2 % (previous year: 8.4 %). The EBIT margin was 5.8 % compared with 3.9 % in the previous year. Therefore, Analytik Jena performed much better on an operating basis than in the previous year.
The Group's tax expense totaled EUR 2.6 m (previous year: EUR 1.1 m). Of this amount, EUR 0.8 m accrues to current actual tax expense and deferred tax income. This corresponds to a tax rate of 27.6 %. In addition, tax expense of EUR 1.8 m includes non-period tax expense resulting from the agreement with the Gera tax office in financial year 2010/2011. The consolidated net profit for the year fell compared with the amount for the previous year by 90.7 % and totaled EUR 0.2 m (previous year: EUR 2.1 m). For the shareholders of Analytik Jena AG both basic and diluted earnings per share amounted to EUR -0.03 (previous year: EUR 0.34).
The Group's total assets as of the balance sheet date on September 30, 2011 remained similar to the previous year's level and amounted to EUR 83.6 m.
As of September 30, 2011, the Group had a total of 802 employees, including 38 interns (previous year: 796 employees, including 49 interns), or 0.8 % more than as of the previous balance sheet date.
With respect to the financial year 2011/2012, Analytik Jena expects that it will be able to achieve further increases in revenue and earnings in all three business units. The Company expects that revenue will be distributed relatively evenly over the quarters and that no major disruptions will be caused by large projects.
"The Company plans further investments in the expansion of the Thuringian manufacturing site in Langewiesen amounting to about EUR 0.7 and remains clearly committed to the manufacturing site Germany. Further important milestones are the market launch of some product innovations that are meant to contribute to the stable growth of the segments. We especially expect good impetus for the expansion of our business from the prestigious international trade fairs IWA in Nuremberg at the beginning of March concerning Optics and the 'analytica' in April in Munich concerning both segments Analytical Instrumentation and Life Science." Berka added.
Contact / Request information
Request further information free of charge:
Analytik Jena AG has established a new subsidiary, Analytik Jena Far East (Thailand) Ltd., giving it a presence in the Southeast Asian market. Analytik Jena AG is using this new company to bolster its activities in the Southeast Asian market, increase its regional service for the sales part ... more
Analytik Jena AG (AJA) expects sales for the current financial year 2012/2013 to exceed EUR 100.0 m for the first time in the Company's history. This was announced today by the manufacturer of analytical instrumentation, life science instruments and optoelectronics in the run-up to its Annu ... more
By extravagant design, flexibility, reliability and high speed FlexCycler² sets new standards for thermal cyclers. more
mercur is a compact system specially optimized for the complete, cost-efficient determination of mercury traces down to the ng level more
The multi EA® 5000 from Analytik Jena sets high standards in the multi-element analysis of C, N, S, Cl as well as TOC and AOX/TOX. Its double furnace more
- 1Thermo Fisher Scientific to Acquire Life Technologies Corporation
- 2analytica Vietnam 2013 – Platform for innovations
- 3Schleicher & Schuell has been purchased by Whatman plc
- 4Inspecting water quality with Raman spectroscopy
- 5LIMS/LIS Market and POCT Supplement
- 6X-ray analysis could boost legumes, thus reducing fertilizer pollution
- 7Abbott Completes Acquisition of Advanced Medical Optics
- 8Thermo Fisher Scientific Scientist Dr. Alexander Makarov Receives Inaugural HUPO Science and Technology Award
- 9Analytik Jena announces forecast for financial year 2012/2013
- 10MDS Sciex Opens Manufacturing Facility in Singapore
- Carl Zeiss Meditec improves its results in first six months of financial yea ...
- ZEISS presents half-year financial figures
- Analytik Jena announces forecast for financial year 2012/2013
- Diagnostics Company SIRS-Lab insolvent
- SeraCare Receives NIH Grant for Recent HIV Infection Rapid Test and Incidenc ...
- Carl Zeiss Meditec improves its results in first six months of financial year 2012/2013
- Evonik selects OPX Biotechnologies for joint development of bio-based chemicals
- ZEISS presents half-year financial figures
- Analytik Jena to develop products for sepsis diagnostics
- Analytik Jena AG establishes subsidiary in Thailand